Clinical Trial Update: TBTC NAA Study: Pilot Study of Surrogate Markers for Outcome of TB Treatment

View source ↗

Summary

The CDC-sponsored TBTC study evaluated surrogate markers to predict tuberculosis treatment outcomes in a completed pilot trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Tuberculosis | Status: COMPLETED